SOURCE: Market Pulse

March 02, 2005 08:30 ET

Market Pulse Breaking News Alert for Wednesday, March 2, 2005: BIPH - Biophan CEO Michael Weiner to Present Today at Wall Street Analyst Forum in New York City, Talk to Be Webcast Live!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA -- (MARKET WIRE) -- March 2, 2005 -- Market Pulse News Alert for this AM, Stocks to Watch are: Biophan Technologies, Inc. (OTC BB: BIPH), Intel Corp. (NASDAQ: INTC), Sirius Satellite Radio Inc. (NASDAQ: SIRI), and Evergreen Solar Inc. (NASDAQ: ESLR).

Investors need to be watching Biophan Technologies, Inc. (OTC BB: BIPH) this AM! Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. Biophan's technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. BIPH just had excellent news out before Wednesday's bell announcing their CEO is presenting at the Wall Street Analyst Forum! Investors should be watching this one closely!

Biophan Technologies, Inc. (OTC BB: BIPH), a developer of next-generation biomedical technology, has announced that Chief Executive Officer, Michael Weiner, will be presenting today at the Wall Street Analyst Forum, an annual conference that brings together analysts and other investment professionals in the financial community. The 16th annual forum runs February 28-March 2, at the Roosevelt Hotel in New York City.

Mr. Weiner will speak on Biophan's progress in improving medical equipment and devices, including making devices function effectively with MRI, and increasing the life span of implantable devices with a new battery with extended life, powered by body heat. His address is scheduled to begin at 11:40 am Eastern. To access the live webcast, visit www.analyst-conference.com and click on the link near the top of the page, labeled, "February 28th-March 2nd, 2005 Webcast." When the schedule of conference events appears, select "Wednesday, March 2," and then select, "Biophan Technologies." The simple webcast registration process will then initiate.

"The Wall Street Analyst Forum and the webcast provide an excellent platform for Biophan and other participating companies to reach interested investors and communicate the latest developments in our fields, as well as to describe important market conditions and opportunities," said Mr. Weiner.

Biophan and its licensors currently hold 108 patents, licenses or patent applications in a range of solutions, many of them involving advances in nanotechnology. The Company possesses a range of proprietary solutions that enable many medical devices and equipment, such as pacemakers and stents, to be used safely and/or effectively with Magnetic Resonance Imaging (MRI) devices. Many medical devices have been difficult to image, or unsafe with MRI, one of the most important imaging tools in medicine. Additional technology can extend the life of implanted devices by converting body heat into electrical power.

About The Wall Street Analyst Forum

The Wall Street Analyst Forum has been sponsoring analyst conferences in New York, Boston and London since 1989. They have involved 2,500 different presenting NYSE/NASDAQ/AMEX corporations and have been attended by more than 15,000 analysts and portfolio managers. Conferences have received coverage in major financial news outlets, including the Wall Street Journal, Barron's, CNBC, Bloomberg and others.

About Biophan Technologies

Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. The Company develops enabling technologies for implanted medical systems such as pacemakers and interventional surgical devices such as catheters, guidewires, stents, and other implants to allow them to be safely and effectively imaged under MRI. The technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Four Biophan technologies include advances in nanotechnology and thin film coatings. Committed to growth through innovation and developmental leadership, Biophan and its licensors now hold a total of 108 U.S. patents, licenses, or applications. This total includes 32 issued U.S. patents, 8 recently-allowed applications that will issue as patents in the near future, and 68 pending applications at various stages of examination at the U.S. Patent and Trademark Office, plus international applications. The patents cover areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, thermoelectric materials for batteries generating power from body heat, and photonics. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. Biophan's goal is to make all biomedical devices capable of safely and successfully working with MRI, and delivering other technologies which will improve quality of life. For more information, please visit www.biophan.com.

Stocks acting well as of late include: Intel Corp. (NASDAQ: INTC), Sirius Satellite Radio Inc. (NASDAQ: SIRI), and Evergreen Solar Inc. (NASDAQ: ESLR).

Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated fifty thousand dollars from Biophan Technologies, Inc. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market Pulse News Alert is a division of MP.

Contact Information